Author

E. Cella

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:database / resource· 1 Approach:experimental assay· 1 Research Focus:genome assembly· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Ballestrero· 1 shared A. Bellodi· 1 shared A. Domnich· 1 shared A. Orsi· 1 shared A. Y. Kim· 1 shared B. Bruzzone· 1 shared B. Cigolini· 1 shared C. Genova· 1 shared

Activity by Year

2022-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Ballestrero

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Biological modifications of the immune response to COVID-19 vaccine in patients treated with rituximab and immune-checkpoint inhibitors

F. Ravera, M. Dameri, I. Lombardo, M. Stabile, N. Fallani, C. Scarsi, B. Cigolini, G. Gentilcore, A. Domnich, L. Zullo, E. Cella, G. Francia, E. Montanari, A. Orsi, A. Bellodi, , G. Zoppoli

This study examines how rituximab and immune-checkpoint inhibitors affect immune responses to a COVID-19 booster vaccine, finding rituximab impairs interferon response and ICI maintains normal immune profiles.

bioRxiv · Mar 5, 2024Immunology

A collaborative approach to improving representation in viral genomic surveillance

P. Kim, A. Y. Kim, J. J. Newman, E. Cella, T. C. Bishop, P. J. Huwe, O. N. Uchakina, R. J. McKallip, V. L. Mack, M. P. Hill, I. V. Ogungbe, O. Adeyinka, S. Jones, G. Ware, J. L. Carroll, , J. P. Kamil

This paper develops a collaborative genomic surveillance model to improve representation in rural and minority communities, generating over 1,000 SARS-CoV-2 genomes and identifying new variants.

bioRxiv · Oct 19, 2022 · PreprintMicrobiology